Drugs / Hib
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01986322 Comparator | Jul 2011 → Jan 2012 | — | PT Bio Farma | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01986322 ↗ |
| Modality | Vaccine | “Group B will receive DTP/HB and Hib Vaccines separately” NCT01986322 ↗ |
| Route | Intramuscular | “Dosage equal to 0.5 mL administered intramuscularly” NCT01986322 ↗ |